In trading on Wednesday, music & electronics stores shares were relative leaders, up on the day by about 2.7%.  Leading the group were shares of Vertiv Holdings, up about 14.5% and shares of Global Industrial off about 0.8% on the day.

Also showing relative strength are dia

Wednesday Sector Leaders: Music & Electronics Stores, Diagnostics  

Labcorp Holdings Inc. reported its financial results for the third quarter ended September 30, 2026, with revenue of $3.81 billion, up 6.9% from $3.56 billion in the third quarter of 2025. Diluted EPS for the quarter was $3.22 compared to $3.12 in the prior year period, while adj

Labcorp Holdings Inc. Reports Third Quarter 2026 Results and Raises Full Year Guidance

(RTTNews) - Labcorp Holdings Inc. (LH) revealed a profit for its third quarter that Increases, from the same period last year

Labcorp Holdings Inc. Announces Rise In Q3 Profit 

(RTTNews) - Labcorp (LH) announced a research collaboration with the U.S. FDA and Charles River Laboratories aimed at advancing the scientific methods used to evaluate whether new medicines have the potential to be abused. The initiative is intended to support safer drug developm

Labcorp, Charles River And FDA Launch Collaboration To Improve Drug Abuse Risk Assessment 

(RTTNews) - Myriad Genetics, Inc. (MYGN), a molecular diagnostic testing and precision medicine company, has entered into a definitive agreement to sell its Prenatal Health testing business to Labcorp Holdings Inc.(LH) for $210 million in cash, plus the value of inventory at clos

Myriad Genetics Surge On $210 Mln Prenatal Testing Business Sale To Labcorp 

(RTTNews) - Laboratory services provider LabCorp Holdings Inc. (LH) announced on Tuesday that it has agreed to acquire the Prenatal Health testing business of molecular diagnostics company Myriad Genetics Inc. (MYGN) for $210 million in cash, plus the value of inventory at closin

Labcorp To Buy Myriad Genetics' Prenatal Testing Business For $210 Mln 

Labcorp Holdings Inc. provides laboratory services. It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing service, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations. In addition, it offers digital pathology solutions, a pathology platforms that support the digitization, centralized review, and sharing of pathology slides; provider and payer digital platforms, an online applications for providers, MCOs, and ACOs; online and mobile applications that enable patients to check offerings, schedule PSC visits, check-in upon PSC arrival, complete documentation, access tests and test results, and manage their accounts; and Generative AI enabled Test Selection, a generative AI enabled tool. It serves clients, third party, medicare/medicaid, patients, pharmaceutical, biotechnology, medical device, diagnostic companies, and CROs. It has a collaboration with the Children's Hospital of Philadelphia to accelerate the discovery, development, and availability of pediatric diagnostics. The company was founded in 1995 and is headquartered in Burlington, North Carolina.

Labcorp Holdings Inc. News